Showing results (1-10 of 533) with videos related to
Sort By:
Pageof 54
HIV Medicine|December 12, 2001
Candidate vaccines for immunotherapy in HIVF M Gotch, N Imami, G HardyImmunological Reviews|November 24, 1999
Therapeutic vaccines in HIV.1 infectionF Gotch, G Hardy, N ImamiExpert Opinion on Biological Therapy|December 1, 2001
Development of immunotherapeutic strategies for HIV-1N Imami, G Hardy, F GotchAIDS Research and Human Retroviruses|December 2, 1999
Assessment of type 1 and type 2 cytokines in HIV type 1-infected individuals: impact of highly active antiretroviral therapyN Imami, C Antonopoulos, G A Hardy, et al.Clinical and Experimental Immunology|October 20, 2005
Immunological and virological consequences of patient-directed antiretroviral therapy interruption during chronic HIV-1 infectionC T Burton, M R Nelson, P Hay, et al.Current Medicinal Chemistry|December 16, 2006
Immune modulation and reconstitution of HIV-1-specific responses: novel approaches and strategiesC T Burton, C M Mela, G Rosignoli, et al.HIV Medicine|March 12, 2004
Evidence of thymic reconstitution after highly active antiretroviral therapy in HIV-1 infectionG Hardy, S Worrell, P Hayes, et al.The Journal of Infectious Diseases|August 19, 2000
Loss of CD4+ T cell proliferative ability but not loss of human immunodeficiency virus type 1 specificity equates with progression to diseaseJ D Wilson, N Imami, A Watkins, et al.HIV Medicine|December 12, 2001
Detection and quantification of HIV-1 specific CD4 helper and CD8 cytotoxic cells: their role in HIV-1-infected individuals and vaccine recipientsN Imami, G Hardy, A Pires, et al.Clinical and Experimental Immunology|October 23, 2002
Impact of NNRTI compared to PI-based highly active antiretroviral therapy on CCR5 receptor expression, beta-chemokines and IL-16 secretion in HIV-1 infectionC T Burton, G A D Hardy, A K Sullivan, et al.Pageof 54